Biogenerics to Drive Protein Therapeutics Markets in Future

Noida, India (PressExposure) August 25, 2009 -- According to our new study “Global Protein Therapeutics Market Analysis” the current market of protein therapeutics is estimated at over US$ 77 Billion and forecasted to grow at a CAGR of around 11.5% during 2010-2012. With going off patents of key blockbusters in protein therapeutics segments, biogenerics is emerging as a key segment in the market. Over the past few years biogenerics has emerged as one the fastest growing segments in global pharmaceutical market.

We have found that biogenerics market is getting boost from increasing demands as it offers low cost treatments as compared to the patented protein therapeutics. This has propelled the growth of investments in the market. Also, high growth projection in this market is attracting more and more companies to make new development, which are being used in treatment of several drastic diseases to help more patients.

Anticipating the current market condition and high investments, the biogenerics market is projected to grow at a CAGR of over 30% during forecasted period. Our research thoroughly analyzes the key markets alongwith factors which are fueling growth into this market. For instance, it says that much of the growth will be driven by European and Asian countries in near future, as they have already approved the regulatory pathways for biogenerics and generic versions of the drugs are being made available there. But the situation in the US is also changing quite rapidly and regulatory pathways for the approval of biogenerics are also likely to be made in the US by the end of 2009. So, a rapid growth is also expected there from 2010 onwards.

Looking at the competitive landscape, the larger companies currently dominate most of the protein therapeutics market on account of their immense researching capability. However, introduction of concepts like intellectual property is expected to encourage the smaller firms to develop and introduce biosimilars of drugs in the market whose patents have already expired. Besides this, our report also briefs the segment-wise and region-wise breakup of global protein therapeutics market. The report highlights key growth factors of other market segments as well.

For FREE SAMPLE of this report visit: []


About RNCOS E-Services Pvt. Ltd.

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Press Release Source:

Press Release Submitted On: August 25, 2009 at 4:37 am
This article has been viewed 20108 time(s).